Skip to main content
FinSpry Logo
FinSpry
BBIO logo
BBIO
(NASDAQ)
BridgeBio Pharma, Inc.
$76.08-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BridgeBio Pharma, Inc. (BBIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BridgeBio Pharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 21 professional research analysts

Consensus Rating

Buy
Based on 21 unique analysts
(29 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$107.64
↑ 41.48% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BBIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
NASDAQ:BBIO
Investing.com
BuyInitiates Coverage
-
Danielle Brill
Truist
BuyMaintains
$102.00 → $107.00
Anupam Rama
JP Morgan
BuyInitiates Coverage
$100.00 → $111.00
Eric Joseph
Citi
HoldMaintains
$93.00 → $94.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Myles Minter
William Blair
BuyReiterates
-
Tyler Van Buren
TD Cowen
BuyInitiates Coverage
$95.00 → $110.00
Jason Zemansky
BofA Securities
BuyReiterates
$104.00
Derek Archila
Wells Fargo
BuyReiterates
$98.00 → $102.00
Sean Laaman
Morgan Stanley
BuyReiterates
$98.00 → $97.00
UK
Investing.com
BuyInitiates Coverage
-
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Ram Selvaraju
HC Wainwright
BuyReiterates
$110.00 → $120.00
Biren Amin
Piper Sandler
BuyMaintains
$111.00
Jason Zemansky
BofA Securities
BuyMaintains
$101.00
Eliana Merle
Barclays
BuyMaintains
$157.00
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Luca Issi
RBC Capital
BuyMaintains
$100.00
Andrew Tsai
Jefferies
BuyMaintains
$100.00
Ahan Chakraborty
Zacks Equity Research
SellInitiates Coverage
-
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Biren Amin
Piper Sandler
BuyMaintains
$111.00
Jason Zemansky
BofA Securities
BuyMaintains
$101.00
Salim Syed
Mizuho
BuyMaintains
$96.00
Salim Syed
Mizuho
BuyMaintains
$96.00
Tiago Fauth
Raymond James
BuyMaintains
$125.00 → $98.00
Salim Syed
Mizuho
BuyMaintains
$106.00 → $96.00
Jason Zemansky
BofA Securities
BuyMaintains
$101.00

Frequently Asked Questions

What is the analyst consensus rating for BBIO?

The analyst consensus rating for BBIO is "Buy" based on 21 analyst recommendations.

What is the average price target for BBIO?

The average 12-month price target for BBIO is $107.64, representing an upside of 41.5% from the current price of $76.08.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.